Compare Cigna Corp (CI) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Novartis AG — how do they compare? Cigna Corp trades at $302.59 (market cap $80.55B), while Novartis AG trades at $150.51 (market cap $293.74B). The key difference: Novartis AG is far larger — about 3.6× Cigna Corp's market cap, and Novartis AG pays the higher dividend (3.09%). Which is the better fit depends on your goals.
| CI | NVS | |
|---|---|---|
Market Cap | $80.55B | $293.74B |
Sector | Health | Health |
52-Week High | $311.00 | $168.62 |
52-Week Low | $244.41 | $113.50 |
Enterprise Value | $103.65B | $333.76B |
Dividend Yield | 2.05% | 3.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
